Wednesday, June 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “ALLERGEN SALES INC [US]”

5 pharma patents match "ALLERGEN SALES INC [US]" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 5
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 5 pharmaceutical patents matching "ALLERGEN SALES INC [US]" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

5 results for “ALLERGEN SALES INC [US]” · 30,257 patents in full index Clear search

  1. US 2002127247

    Modified clostridial neurotoxins with altered biological persistence

    ALLERGEN SALES INC [US] · Granted Sep 12, 2002 · Expires Sep 7, 2022

    expired

  2. US 6313163

    2,4-pentadienoic acid derivatives having retinoid-like biological activity

    ALLERGEN SALES INC [US] · Granted Nov 6, 2001 · Expires Nov 1, 2021

    expired

  3. CN 1311670

    Cholinergic agents in the treatment of presbyopia

    ALLERGEN SALES INC [US] · Granted Sep 5, 2001 · Expires Aug 31, 2021

    expired

  4. CN 1291100

    Cyclopentane Heptan (ene) oic acid, 2-hetero arylakenyl derivatives and therapeutic agents

    ALLERGEN SALES INC [US] · Granted Apr 11, 2001 · Expires Apr 6, 2021

    expired

  5. CN 1284066

    Substituted inidazole derivatives having agonist-like activity at alpha 2B or 2B/2C adrenergic receptors

    ALLERGEN SALES INC [US] · Granted Feb 14, 2001 · Expires Feb 9, 2021

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.